Kim, Min Kyoung <br/><br/>
Risk factors for erlotinib-induced hepatotoxicity: a retrospective follow-up study.  [electronic resource] 

 -  BMC cancer  Oct 2018 
 - 988 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-018-4891-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cytochrome P-450 CYP3A Inducers--therapeutic use<br/>Erlotinib Hydrochloride--adverse effects<br/>Female<br/>Humans<br/>Liver--drug effects<br/>Liver Neoplasms--secondary<br/>Male<br/>Middle Aged<br/>Pancreatic Neoplasms--drug therapy<br/>Retrospective Studies